Crestchem Ltd

As of June 30, 2026, Crestchem Ltd carries a market capitalization of 387.00M, placing it among publicly traded companies globally. Its enterprise value stands at 387.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Crestchem Ltd has 3.00M shares outstanding.

As of June 30, 2026, Crestchem Ltd trades at a trailing price-to-earnings ratio of 11.70.

As of June 30, 2026, Crestchem Ltd trades at an EV/EBITDA multiple of 9.77 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.93 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 387.00M versus a market cap of 387.00M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 75.19M in revenue per employee across its workforce of 4.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Crestchem Ltd recorded 13.01M in income tax expense. That works out to an effective tax rate of 28.23, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 46.08M, leaving 33.07M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Crestchem Ltd's stock has gained approximately 21.01% over the past 52 weeks. The 50-day moving average sits at 142.64, while the 200-day moving average is 119.37.

Over the twelve months ended June 30, 2026, Crestchem Ltd generated 338.34M in revenue and converted that into 33.07M in net income, yielding earnings per share of 11.02. EBITDA reached 39.60M, while operating income came in at 38.97M.

Over the twelve months ended June 30, 2026, Crestchem Ltd posted a gross margin of 22.26, reflecting its pricing power and cost economics. The operating margin of 11.52 and net profit margin of 9.77 provide insight into operational efficiency.